BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, February 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 3, 2003
View Archived Issues
NeuGene antisense drugs make progress in infectious disease program
Read More
Genzyme and MacroGenics collaborate on therapies for immune-mediated disease
Read More
Tripep identifies new candidate drug for HIV
Read More
Good gastrointestinal safety profile reported for licofelone in osteoarthritis patients
Read More
MMF as effective as i.v. cyclophosphamide in severe lupus nephritis
Read More
Doxycycline associated with benefits in osteoarthritis of the knee, rheumatoid arthritis
Read More
Absence of causal relationship reported for lymphoma and anti-TNF-alpha drugs
Read More
Potential therapeutic effects of atorvastatin in rheumatoid arthritis
Read More
Improved organ function and reduced mortality described for drotrecogin alfa (activated) in sepsis
Read More
Abbott claims new Bcl-XL/Bcl-2 inhibitors and their use in cancer therapy
Read More
New nitrooxy-containing probucol analogues recently patented by NicOx
Read More
Novel NPY antagonists prepared and tested at Banyu
Read More
GSK presents new inhibitors of Msk-1 and/or Rho kinases
Read More
New adamantane-based P2X7 antagonists under study at AstraZeneca
Read More
Antitumor fredericamycin analogues developed at Biofrontera
Read More
AstraZeneca scientists identify novel chemokine CCR5 modulators
Read More
New antihistaminic agents in early development at Sun Pharmaceutical
Read More
Synagis approved for expanded use in Europe
Read More
Risperdal Consta receives FDA approval
Read More
Seroquel deemed approvable by the FDA
Read More
Actimid enters phase II trial for prostate cancer
Read More
Chiron to initiate phase III tifacogin study in severe community-acquired pneumonia
Read More
Celltech gains European rights to Xyrem
Read More
Pfizer submits sNDA for Geodon for acute bipolar mania
Read More
TC-1734 successfully completes two phase I studies
Read More
Potent antiinflammatory effects described for new p38 kinase inhibitor
Read More
New triazoles from Meiji Seika exert in vitro and in vivo antifungal activity
Read More
FLG retains high efficacy against mutant HBV
Read More
